{
  "id": 11476087,
  "title": "Clinical Trial Quality: “Good Enough” Isn’t Good Enough For Patients",
  "url": "https://urgent.news/2026/10/02/clinical-trial-quality-good-enough-isnt-good-enough-for-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-02T14:46:29.000Z",
  "source": {
    "name": "Forbes",
    "slug": "forbes",
    "url": "https://www.forbes.com/sites/forbesbooksauthors/2026/10/02/clinical-trial-quality-good-enough-isnt-good-enough-for-patients/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}